These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2305025)

  • 21. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of oral contraceptives on well-being and sexuality.
    Bancroft J; Sartorius N
    Oxf Rev Reprod Biol; 1990; 12():57-92. PubMed ID: 2075004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal ultrasonographic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect pill intake.
    Hamilton CJ; Hoogland HJ
    Am J Obstet Gynecol; 1989 Nov; 161(5):1159-62. PubMed ID: 2686444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian activity during regular oral contraceptive use.
    Crosignani PG; Testa G; Vegetti W; Parazzini F
    Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.
    Elomaa K; Lähteenmäki P
    Contraception; 1999 Nov; 60(5):275-9. PubMed ID: 10717779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of various oral contraceptive combinations on premenstrual symptoms.
    Andersch B
    Int J Gynaecol Obstet; 1982 Dec; 20(6):463-9. PubMed ID: 6130993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
    Masson S; Franssen E; Hilditch JR; Powell MG
    Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol.
    Greco T; Graham CA; Bancroft J; Tanner A; Doll HA
    Contraception; 2007 Jul; 76(1):8-17. PubMed ID: 17586130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives.
    Coffee AL; Kuehl TJ; Sulak PJ
    Pharmacotherapy; 2008 May; 28(5):576-83. PubMed ID: 18447656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian follicles during oral contraceptive cycles: their potential for ovulation.
    Killick SR
    Fertil Steril; 1989 Oct; 52(4):580-2. PubMed ID: 2680616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical use of biphasic and triphasic pills.
    Cohen J
    IPPF Med Bull; 1985 Aug; 19(4):1-2. PubMed ID: 12280230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-cycle treatment in oral contraception].
    Kuhl H; Birkhäuser M; Mueck A; Neulen J; Thaler C; Kiesel L; Braendle W
    Ther Umsch; 2009 Feb; 66(2):101-8. PubMed ID: 19180430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
    Weber-Diehl F; Lehnert J; Lachnit U
    Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration.
    Joffe H; Cohen LS; Harlow BL
    Am J Obstet Gynecol; 2003 Dec; 189(6):1523-30. PubMed ID: 14710055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
    Dunson TR; McLaurin VL; Aguayo EL; de Silva P; Calventi V; Gerais AS; Serani RG
    Contraception; 1993 Jun; 47(6):515-25. PubMed ID: 8334888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.